Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.

per Kinzig, M, Sörgel, F, Brismar, B, Nord, C E
Publicat 1992

Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.

per Foitzik, T, Hotz, H G, Kinzig, M, Sörgel, F, Buhr, H J
Publicat 1997

Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.

per Uehlinger, D E, Schaedeli, F, Kinzig, M, Sörgel, F, Frey, F J
Publicat 1996

Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

per Nau, R, Kinzig, M, Dreyhaupt, T, Kolenda, H, Sörgel, F, Prange, H W
Publicat 1994

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

per Bulitta, J. B., Landersdorfer, C. B., Kinzig, M., Holzgrabe, U., Sorgel, F.
Publicat 2009

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

per Lodise, T. P., Sorgel, F., Melnick, D., Mason, B., Kinzig, M., Drusano, G. L.
Publicat 2011

Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.

per Van der Auwera, P, Duchateau, V, Lambert, C, Husson, M, Kinzig, M, Sörgel, F
Publicat 1993

Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.

per Incavo, S J, Ronchetti, P J, Choi, J H, Wu, H, Kinzig, M, Sörgel, F
Publicat 1994

Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers

per Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Holzgrabe, U., Stephan, U., Sörgel, F.
Publicat 2011

Blood, Tissue, and Intracellular Concentrations of Erythromycin and Its Metabolite Anhydroerythromycin during and after Therapy

per Krasniqi, S., Matzneller, P., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., Zeitlinger, M.
Publicat 2012

Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy

per Matzneller, P., Krasniqi, S., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., Zeitlinger, M.
Publicat 2013

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

per Nau, R, Prange, H W, Kinzig, M, Frank, A, Dressel, A, Scholz, P, Kolenda, H, Sörgel, F
Publicat 1996

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

per Bulitta, J. B., Landersdorfer, C. B., Hüttner, S. J., Drusano, G. L., Kinzig, M., Holzgrabe, U., Stephan, U., Sörgel, F.
Publicat 2010

Impact of Spore Biology on the Rate of Kill and Suppression of Resistance in Bacillus anthracis

per Drusano, G. L., Okusanya, O. O., Okusanya, A. O., van Scoy, B., Brown, D. L., Fregeau, C., Kulawy, R., Kinzig, M., Sörgel, F., Heine, H. S., Louie, A.
Publicat 2009

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer

per Diekstra, MH, Fritsch, A, Kanefendt, F, Swen, JJ, Moes, DJAR, Sörgel, F, Kinzig, M, Stelzer, C, Schindele, D, Gauler, T, Hauser, S, Houtsma, D, Roessler, M, Moritz, B, Mross, K, Bergmann, L, Oosterwijk, E, Kiemeney, LA, Guchelaar, HJ, Jaehde, U
Publicat a CPT Pharmacometrics Syst Pharmacol (2017)